|
|
Volumn 44, Issue 11, 1995, Pages 1249-1258
|
|
U.K. Prospective diabetes study 16: Overview of 6 years' therapy of type II diabetes: A progressive disease
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA GLUCOSIDASE INHIBITOR;
BIGUANIDE;
CHLORPROPAMIDE;
GLIBENCLAMIDE;
GLIPIZIDE;
GLUCOSE;
HEMOGLOBIN A1C;
INSULIN;
INSULIN ZINC SUSPENSION;
ISOPHANE INSULIN;
METFORMIN;
PHENFORMIN;
PLACEBO;
SULFONYLUREA;
TOLBUTAMIDE;
ADULT;
AGED;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETES CONTROL;
DIET THERAPY;
DOSE RESPONSE;
FEMALE;
GLUCOSE BLOOD LEVEL;
GLUCOSE HOMEOSTASIS;
HUMAN;
HYPOGLYCEMIA;
INSULIN TREATMENT;
MAJOR CLINICAL STUDY;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PANCREAS ISLET BETA CELL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SIDE EFFECT;
SUBCUTANEOUS DRUG ADMINISTRATION;
WEIGHT GAIN;
|
|
EID: 0028817815
PISSN: 00121797
EISSN: None
Source Type: Journal
DOI: 10.2337/diabetes.44.11.1249 Document Type: Review |
|
Times cited : (1953)
|
|
References (0)
|